Papaya
- Generic Name
- Papaya
- Drug Type
- Biotech
- Unique Ingredient Identifier
- KU94FIY6JB
- Background
Papaya allergenic extract is used in allergenic testing.
The Efficient Brain Study
Phase 2
Completed
- Conditions
- Metabolism - Cerebral Energy
- Interventions
- Other: Granulated Sugar
- First Posted Date
- 2016-05-13
- Last Posted Date
- 2019-10-17
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 30
- Registration Number
- NCT02771366
- Locations
- 🇺🇸
University of Florida Institute on Aging, Gainesville, Florida, United States
Papaya Study ID:20140628
Phase 1
Completed
- Conditions
- AgingSystemic Inflammation
- Interventions
- Drug: Sugar Pill
- First Posted Date
- 2014-01-31
- Last Posted Date
- 2018-04-09
- Lead Sponsor
- University of Florida
- Target Recruit Count
- 30
- Registration Number
- NCT02051634
- Locations
- 🇺🇸
University of Florida, Gainesville, Florida, United States
The Efficacy and Safety of Topical Papaya (Carica Papaya) Leaf Extract 1% Ointment Versus Mupirocin 2% Ointment in the Treatment of Limited Impetigo: a Randomized, Double-blind, Controlled Clinical Trial
- First Posted Date
- 2013-09-16
- Last Posted Date
- 2013-12-19
- Lead Sponsor
- Philippine Dermatological Society
- Target Recruit Count
- 128
- Registration Number
- NCT01943136
- Locations
- 🇵ðŸ‡
St. Luke's Medical Center, Quezon City, NCR, Philippines
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath